197 related articles for article (PubMed ID: 17383302)
1. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
Soja AM; Zwisler AD; Frederiksen M; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Am Heart J; 2007 Apr; 153(4):621-8. PubMed ID: 17383302
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
[TBL] [Abstract][Full Text] [Related]
3. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial.
Zwisler AD; Soja AM; Rasmussen S; Frederiksen M; Abedini S; Appel J; Rasmussen H; Gluud C; Iversen L; Sigurd B; Madsen M; Fischer-Hansen J;
Am Heart J; 2008 Jun; 155(6):1106-13. PubMed ID: 18513526
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation.
Hindman L; Falko JM; LaLonde M; Snow R; Caulin-Glaser T
Am Heart J; 2005 Nov; 150(5):1046-51. PubMed ID: 16290994
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
8. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
9. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes.
Rivero K; Portal VL; Vieira M; Behle I
Diabetes Res Clin Pract; 2008 Mar; 79(3):433-7. PubMed ID: 18045723
[TBL] [Abstract][Full Text] [Related]
11. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
12. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.
McGavock JM; Lingvay I; Zib I; Tillery T; Salas N; Unger R; Levine BD; Raskin P; Victor RG; Szczepaniak LS
Circulation; 2007 Sep; 116(10):1170-5. PubMed ID: 17698735
[TBL] [Abstract][Full Text] [Related]
13. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
14. Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence.
Arrigo I; Brunner-LaRocca H; Lefkovits M; Pfisterer M; Hoffmann A
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):306-11. PubMed ID: 18525385
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
[TBL] [Abstract][Full Text] [Related]
17. Skin tag as a cutaneous marker for impaired carbohydrate metabolism: a case-control study.
Rasi A; Soltani-Arabshahi R; Shahbazi N
Int J Dermatol; 2007 Nov; 46(11):1155-9. PubMed ID: 17988334
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial)--design, intervention, and population.
Zwisler AD; Schou L; Soja AM; Brønnum-Hansen H; Gluud C; Iversen L; Sigurd B; Madsen M; Fischer-Hansen J;
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290957
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of glucose tolerance status in patients with asthma bronchiale.
Gulcan E; Bulut I; Toker A; Gulcan A
J Asthma; 2009 Mar; 46(2):207-9. PubMed ID: 19253132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
